Related Experiment Video
Updated: Mar 25, 2026

10:05
Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
8.7K
Genome-wide footprinting: ready for prime time?
Myong-Hee Sung1, Songjoon Baek1, Gordon L Hager1
1Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA.
Nature Methods
|February 26, 2016
Summary
Digital genomic footprinting using DNase I probes accessible chromatin for regulatory site identification. However, recent studies reveal limitations in detecting short-lived protein binding, prompting reassessment of this genomics technique.
Area of Science:
- Genomics
- Molecular Biology
- Epigenetics
Background:
- High-throughput sequencing enables genome-wide profiling of molecular biology assays.
- Accessible chromatin regions, identified using DNase I, contain crucial regulatory elements like promoters and enhancers.
- Digital genomic footprinting infers protein occupancy at the nucleotide level from DNase-seq data.
Purpose of the Study:
- To evaluate the utility and limitations of digital genomic footprinting.
- To compare digital genomic footprinting with chromatin immunoprecipitation followed by sequencing (ChIP-seq).
- To summarize current consensus and differing views on genomic footprinting's scope and robustness.
Main Methods:
- Analysis of DNase-seq libraries and computational processing of cut profiles.
- Review of recent reports and community discussions on genomic footprinting.
- Identification of limitations, particularly for transcription factor (TF) binding.
Main Results:
- Digital genomic footprinting offers a potential alternative to ChIP-seq, theoretically overcoming antibody and resolution issues.
- Recent findings highlight limitations in detecting protein occupancy, especially for TFs with transient chromatin interactions.
- The genomics community is actively debating the reliability and scope of genomic footprinting.
Conclusions:
- Genomic footprinting shows promise but faces challenges regarding the detection of certain protein-DNA interactions.
- Further reassessment is needed to establish the robust deliverables of genomic footprinting methods.
- Understanding these limitations is crucial for advancing genome-wide regulatory site analysis.
Related Concept Videos
Genome-wide Association Studies-GWAS
16.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.6K
DNA Microarrays
22.7K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
22.7K

